Type in a topic service or offering and then hit enter to search
With newly emerging care and payment models, incentive realignment, the growth of online insurance exchanges and the rise of consumerism—change is constant and often complex.
Together, Cognizant and TriZetto are helping payers achieve new levels of productivity, while harnessing the power of new digital business capabilities to enrich the consumer experience and drive better outcomes.
The Affordable Care Act and Its Impact on Workers’ Compensation
While the Affordable Care Act (ACA) is expected to reduce the number of uninsured and improve personal wellness in the U.S., the law's changes in workforce definitions will significantly impact workforce dynamics, employee hiring, employers' benefits strategies and wellness programs—requiring a reevaluation of how workers' compensation is accounted for and delivered.
Identifying Key Opinion Leaders Using Social Network Analysis
In the pharmaceutical industry, locating key opinion leaders (KOLs) is essential—and very difficult—for clinical trials and other assessments. We provide a method and an in‑depth example of using social network analysis (SNA) to identify these critical players.
Enterprise Risk Management: Minimizing Exposure, Fostering Innovation and Accelerating Growth
Formal policies and processes for enterprise risk management (ERM) are common among large corporations, such as those in finance and healthcare. However, most technology‑focused companies consider ERM an obstacle to innovation. When properly implemented and maintained, an enterprise risk management program can lessen risk, accelerate strategic development, drive innovation and bolster bottom‑line growth.
Making Life Easier for Investigators: A Shared Solution for Smarter, Faster Clinical Trials
The industry's Shared Investigator Platform significantly reduces the time and cost of clinical trials, simplifying work for investigators and bringing promising therapies to market more quickly.
The Rise of the Smart Product Economy
Making products smart can deliver game‑changing innovation, enriched customer experiences and new, across‑the‑board levels of efficiency. Our latest research reveals practical steps business leaders can take to benefit from this quickly intensifying and accelerating trend.
Real‑World Evidence: A Better Life Journey for Pharmas, Payers and Patients
Driven partly by regulatory pressure, stakeholders in the healthcare ecosystem—including payers and patients—now want real-world evidence (RWE) about wellness to supplement and expand randomized control trial (RCT) input from pharmas about pharmaceuticals' efficacy and effectiveness.
Using Advanced Analytics, Drug Makers Reach Decision-Makers More Effectively
By analyzing digital footprints, pharma companies can better identify key influencers throughout their integrated delivery networks.
How Pharma Can Fully Digitize Interactions with Healthcare Professionals
By building end-to-end IT ecosystems and understanding preferred communications channels, pharmaceutical companies can create more engaging and fruitful digital relationships with healthcare professionals.
Employee Wellness: Two Parts Perspiration, One Part Persistence
With employee health affecting bottom lines, organizations need to support preemptive initiatives that encourage both personal wellness and quantifiable results. Here's how we are addressing this major challenge.
Medication Adherence in the Real World
Medication non-adherence is a growing concern, as it is increasingly associated with negative health outcomes and higher cost of care. Tackling the burden of non-adherence requires a collaborative, patient-centric approach that considers individual patient needs and results in intelligent interventions that combine high-tech with high-touch.
Cognizant and TriZetto offer a unique end-to-end healthcare solution suite developed to simplify deployment and adoption of technology and improve operations. The healthcare expertise and services provided are designed to maximize the potential of each client’s current technology investments.